A tropical jasmine shrub whose extract could relieve pain without side effects – it sounds almost too good to be true. Conolidine, promoted by companies like Cerebro Global as a “natural alternative” for pain relief, raises high expectations.
What exactly is this substance, what does science say about its effectiveness as a painkiller, and what caveats should we note about the hype?
In this article, we dive into the background of conolidine with an accessible yet critical perspective.
What is conolidine and where does it come from?
Conolidine is a rare indole alkaloid that was first isolated in 2004 from the bark of Tabernaemontana divaricata, better known as crepe jasmine or pinwheel flower.
The complete chemical structure was synthetically replicated in 2011 by a team at the Scripps Research Institute, making larger quantities available for research.
In traditional Southeast Asian medicine, the plant extract had been used for centuries against wounds and toothache, but people had no knowledge of the specific molecule that might be responsible for the pain-relieving effects.
Does conolidine really work as a natural pain reliever?
The hype around conolidine began when mouse studies showed it relieved pain as effectively as morphine, but without the classic opioid side effects.
This emerged from a study published in Nature Chemistry in 2011, in which synthetic conolidine was tested on various pain models. Since then, the substance has been promoted by wellness companies as a “natural morphine alternative.”
Despite this optimism, there are currently no published clinical studies in humans, not even in 2025. The positive results are limited to in vitro and animal models, a point also emphasized by a recent review in the Journal of Pain Research from 2022.
How would it work? A look at the science
Conolidine does not act on the classic μ-opioid receptor. Researchers at the Luxembourg Institute of Health discovered that it instead binds to the so-called ACKR3 receptor, also known as CXCR7.
This receptor functions as a “cleanup sponge” for the body’s own opioid peptides. By blocking ACKR3, endorphins remain in circulation longer, which indirectly enhances pain relief.
This discovery was made public in 2021 in a study in Signal Transduction and Targeted Therapy and later summarized in popular science terms on ScienceDaily. Because conolidine works outside the classic opioid pathway, researchers observed no respiratory depression, constipation, or sedation in mice.
Why hasn’t conolidine been widely accepted yet?
Although unfamiliarity with the precise mechanism of action need not be a deal-breaker — consider paracetamol and various anesthetic agents, whose molecular puzzle is also not fully solved — those drugs do have decades of clinical experience, large phase III studies, and worldwide post-marketing surveillance behind them. That robust safety foundation is currently completely lacking for conolidine.
Possible side effects and risks
In animal studies, no serious side effects have been observed so far. Yet it remains unknown how conolidine behaves in human metabolism.
A critical review in Topics in Pain Management from 2024 warns of possible gastrointestinal complaints, fatigue, or interference with the immune system – purely hypothetical, but a hint that caution is warranted.
Additionally, supplements containing conolidine often contain plant extract with varying purity. Other alkaloids from Tabernaemontana species can produce cardiac or psychoactive effects, increasing the risk of unwanted side effects.
Nuance: promise with critical caveats
Comparisons to morphine are premature; morphine has more than a century of clinical data, while conolidine has not progressed beyond animal testing. Yet the promise of a painkiller without addiction and respiratory depression is enticing.
Experts, such as chemist Glenn Micalizio of Scripps, call it “a fascinating starting point for new drug development,” but emphasize that more research is needed before the substance reaches the pharmacy.
Until then, it’s advisable to take supplements with a grain of salt and always consult a doctor for chronic pain. Conolidine may not be “magic morphine,” but it’s also not nonsense: it’s a promising molecule in an early stage.
Verified Sources
- Wikipedia: Conolidine – General background information on conolidine and the Tabernaemontana divaricata plant.
- Nature Chemistry (2011) – Publication on the synthetic production of conolidine and early animal trials.
- PMC: ACKR3 as a target of conolidine – Study on the mechanism of action of conolidine via the ACKR3 receptor.
- ScienceDaily (2021) – Popular science summary of findings on ACKR3.
- Journal of Pain Research (2022) – Review of available preclinical data on conolidine.
- Topics in Pain Management (2024) – Critical analysis of conolidine as a possible morphine alternative.
- Signal Transduction and Targeted Therapy (2021) – Research on the pharmacological profile of conolidine.
- Nature News (2011) – Interview and background on the discovery of synthetic conolidine.
- MedKoo Biosciences – Description of the mechanism of action, receptor binding, and preclinical applications of conolidine.
Related Articles
Frequently Asked Questions
What is conolidine and what is it used for?
Conolidine is a rare alkaloid derived from the Tabernaemontana divaricata plant. It is being investigated for possible pain-relieving properties without the typical side effects of opioids.
Is conolidine approved by the FDA?
Conolidine is not yet approved by the FDA as a medication. It is currently in preclinical and early clinical studies.
Who created conolidine?
Conolidine occurs naturally in the crepe jasmine plant. Chemical synthesis of the substance was first successfully performed by researchers in 2011, but it is not the creation of a single individual.
What is the new painkiller that was just approved by the FDA?
Recently, the FDA has approved a new pain-relieving medication, depending on the latest press releases, this is a non-opioid painkiller with a unique mechanism of action. The exact name varies with each FDA update.
Is Clonidine approved by the FDA for ADHD?
Yes, Clonidine is FDA-approved for treating ADHD, particularly to help with sleep problems and behavioral issues in children.
